Shikonin inhibits epithelial-mesenchymal transition in glioblastoma cells by upregulating p53 and promoting miR-361-5p level to suppress ZEB1 expression
Abstract Objective Shikonin, an active compound from the rhizome of Lithospermum erythrorhizon, exerts anti-tumor effects in various cancers, including glioblastoma multiforme (GBM). This study explored the mechanism of Shikonin for inhibiting the migration and invasion of GBM cells, providing a rat...
Saved in:
| Main Authors: | Fengying Zhang, Zhiyi Liu, Yingbin Wang, Lin Zuo, Sicong Xu, Yin Liu, Hao Liang, Yixue Xue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Neuroscience |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12868-025-00956-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-361-5p contributes to the pathogenesis of Alzheimer’s disease
by: Abbas Jalaiei, et al.
Published: (2025-08-01) -
Ultrasound-activated miR-195-5p/shikonin nanobubbles remodel immunosuppressive microenvironment via immunogenic cell death to potentiate PD-1/PD-L1 blockade in hepatocellular carcinoma
by: Yandi Tan, et al.
Published: (2025-10-01) -
Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT/GPX4 regulatory axis
by: Rui Huang, et al.
Published: (2024-12-01) -
The Role of Insulin Receptor Substrate 4 (IRS4) Protein in the Radiotherapy Response of Glioblastoma Multiforme (GBM) Cells
by: Gökhan Görgişen, et al.
Published: (2024-10-01) -
Epigenetic mechanisms of plasticity and resistance in glioblastoma: therapeutic targets and implications
by: Farzaneh Amirmahani, et al.
Published: (2025-05-01)